Influenza Drugs Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032
- Report ID: ME_0065107
- Format: Electronic (PDF)
- Publish Type:
- Number of Pages: 250
Market Snapshot
CAGR:7.73
Source: Market Expertz
| Study Period | 2019-2032 |
| Base Year | 2023 |
| Forcast Year | 2023-2032 |
| CAGR | 7.73 |
Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries
Download Sample PdfReport Overview
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of Influenza Drugs in these regions, from 2014 to 2026 (forecast), coveringAsia-Pacific (China, Japan, Korea, India and Southeast Asia)
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
South America (Brazil, Argentina, Columbia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global Influenza Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Roche
Shionogi
Cipla
Sun Pharmaceutical
GlaxoSmithKline
Mitsubishi Chemical
Daiichi Sankyo
ADMA Biologics
Teva
CSL
Sanofi
AstraZeneca
Biondvax
HEC
China Resources Sanjiu
BaiYunShan General Factory (BYS)
Livzon Pharm
Northeast Pharm
Others
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Oseltamivir
Zanamivir
Amantadine
Rimantadine
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Influenza Drugs for each application, including
Hospital
Pharmacy
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Influenza Drugs Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Influenza Drugs Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Oseltamivir Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Zanamivir Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.3 Amantadine Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.4 Rimantadine Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Influenza Drugs Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Influenza Drugs Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Influenza Drugs Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Influenza Drugs Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Influenza Drugs Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Influenza Drugs Market Assessment by Type
8.1 Asia Pacific Influenza Drugs Market Assessment by Application (Consumption and Market Share)
8.2 North America Influenza Drugs Market Assessment by Application (Consumption and Market Share)
8.3 Europe Influenza Drugs Market Assessment by Application (Consumption and Market Share)
8.4 South America Influenza Drugs Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Influenza Drugs Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Roche
9.1.1 Roche Profiles
9.1.2 Roche Product Portfolio
9.1.3 Roche Influenza Drugs Business Performance
9.1.4 Roche Influenza Drugs Business Development and Market Status
9.2 Shionogi
9.2.1 Shionogi Profiles
9.2.2 Shionogi Product Portfolio
9.2.3 Shionogi Influenza Drugs Business Performance
9.2.4 Shionogi Influenza Drugs Business Development and Market Status
9.3 Cipla
9.3.1 Cipla Profiles
9.3.2 Cipla Product Portfolio
9.3.3 Cipla Influenza Drugs Business Performance
9.3.4 Cipla Influenza Drugs Business Development and Market Status
9.4 Sun Pharmaceutical
9.4.1 Sun Pharmaceutical Profiles
9.4.2 Sun Pharmaceutical Product Portfolio
9.4.3 Sun Pharmaceutical Influenza Drugs Business Performance
9.4.4 Sun Pharmaceutical Influenza Drugs Business Development and Market Status
9.5 GlaxoSmithKline
9.5.1 GlaxoSmithKline Profiles
9.5.2 GlaxoSmithKline Product Portfolio
9.5.3 GlaxoSmithKline Influenza Drugs Business Performance
9.5.4 GlaxoSmithKline Influenza Drugs Business Development and Market Status
9.6 Mitsubishi Chemical
9.6.1 Mitsubishi Chemical Profiles
9.6.2 Mitsubishi Chemical Product Portfolio
9.6.3 Mitsubishi Chemical Influenza Drugs Business Performance
9.6.4 Mitsubishi Chemical Influenza Drugs Business Development and Market Status
9.7 Daiichi Sankyo
9.7.1 Daiichi Sankyo Profiles
9.7.2 Daiichi Sankyo Product Portfolio
9.7.3 Daiichi Sankyo Influenza Drugs Business Performance
9.7.4 Daiichi Sankyo Influenza Drugs Business Development and Market Status
9.8 ADMA Biologics
9.8.1 ADMA Biologics Profiles
9.8.2 ADMA Biologics Product Portfolio
9.8.3 ADMA Biologics Influenza Drugs Business Performance
9.8.4 ADMA Biologics Influenza Drugs Business Development and Market Status
9.9 Teva
9.9.1 Teva Profiles
9.9.2 Teva Product Portfolio
9.9.3 Teva Influenza Drugs Business Performance
9.9.4 Teva Influenza Drugs Business Development and Market Status
9.10 CSL
9.10.1 CSL Profiles
9.10.2 CSL Product Portfolio
9.10.3 CSL Influenza Drugs Business Performance
9.10.4 CSL Influenza Drugs Business Development and Market Status
9.11 Sanofi
9.12 AstraZeneca
9.13 Biondvax
9.14 HEC
9.15 China Resources Sanjiu
9.16 BaiYunShan General Factory (BYS)
9.17 Livzon Pharm
9.18 Northeast Pharm
9.19 Others
10 World Influenza Drugs Market Assessment by Players
10.1 Global Influenza Drugs Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Influenza Drugs Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Influenza Drugs Price (USD/Unit) of Players 2014-2020
10.4 Global Influenza Drugs Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Influenza Drugs Sales Assessment of Players 2014-2020
11.1.2 North America Influenza Drugs Revenue Assessment of Players 2014-2020
11.1.3 North America Influenza Drugs Price Assessment of Players 2014-2020
11.1.4 North America Influenza Drugs Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Influenza Drugs Sales Assessment of Players 2014-2020
11.2.2 Europe Influenza Drugs Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Influenza Drugs Price Assessment of Players 2014-2020
11.2.4 Europe Influenza Drugs Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Influenza Drugs Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Influenza Drugs Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Influenza Drugs Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Influenza Drugs Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Influenza Drugs Sales Assessment of Players 2014-2020
11.4.2 South America Influenza Drugs Revenue Assessment of Players 2014-2020
11.4.3 South America Influenza Drugs Price Assessment of Players 2014-2020
11.4.4 South America Influenza Drugs Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Influenza Drugs Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Influenza Drugs Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Influenza Drugs Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Influenza Drugs Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Influenza Drugs Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Influenza Drugs Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Influenza Drugs Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Influenza Drugs Sales by Countries/Regions 2014-2020
12.2.2 North America Influenza Drugs Revenue by Countries/Regions 2014-2020
12.2.3 North America Influenza Drugs Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Influenza Drugs Sales by Countries/Regions 2014-2020
12.3.2 Europe Influenza Drugs Revenue by Countries/Regions 2014-2020
12.3.3 Europe Influenza Drugs Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Influenza Drugs Sales by Countries/Regions 2014-2020
12.4.2 South America Influenza Drugs Revenue by Countries/Regions 2014-2020
12.4.3 South America Influenza Drugs Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Influenza Drugs Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Influenza Drugs Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Influenza Drugs Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Influenza Drugs Sales & Revenue Forecast 2021-2026
14.1 World Influenza Drugs Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World Influenza DrugsSales and Market Share by Regions
14.1.2 World Influenza DrugsRevenue and Market Share by Regions
15 Asia Influenza Drugs Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 Oseltamivir
15.1.2 Zanamivir
15.1.3 Amantadine
15.1.4 Rimantadine
15.2 Consumption Forecast by Application, 2021-2026
16 North America Influenza Drugs Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 Oseltamivir
16.1.2 Zanamivir
16.1.3 Amantadine
16.1.4 Rimantadine
16.2 Consumption Forecast by Application, 2021-2026
17 Europe Influenza Drugs Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 Oseltamivir
17.1.2 Zanamivir
17.1.3 Amantadine
17.1.4 Rimantadine
17.2 Consumption Forecast by Application, 2021-2026
18 South America Influenza Drugs Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 Oseltamivir
18.1.2 Zanamivir
18.1.3 Amantadine
18.1.4 Rimantadine
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Influenza Drugs Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 Oseltamivir
19.1.2 Zanamivir
19.1.3 Amantadine
19.1.4 Rimantadine
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Influenza Drugs Price (USD/Unit) Trend 2021-2026
20.2 Global Influenza Drugs Gross Profit Trend 2021-2026
21 Conclusion
List of Tables and Figures
Figure Product Picture of Influenza Drugs
Table Players List in the Report
Table Mergers & Acquisitions, Expansion Plans
Table Global Influenza Drugs Market Size (Volume) and Growth Rate by Type (2019-2026)
Global Influenza Drugs Market Share by Application (2019-2026)
Figure Industry Chain Structure of Influenza Drugs
Table Product Application and Standard
Table Key Suppliers of Raw Material/Components
Figure Industry Chain Structure of Influenza Drugs
Table Representative Downstream Enterprises of Influenza Drugs
Figure New Project SWOT Analysis of Influenza Drugs
Table Industry Policy List of Influenza Drugs 2019
Table World Influenza Drugs Sales (Unit) by Type (2014-2020)
Figure World Influenza Drugs Sales Market Share (%) by Type 2014-2020
Table World 2014-2020 Influenza Drugs Revenue (M USD) by Type
Figure World Influenza Drugs Revenue Market Share (%) by Type 2014-2020
Table Oseltamivir-Sales (K Units), Revenue and Growth Rate
Table Zanamivir-Sales (K Units), Revenue and Growth Rate
Table Amantadine-Sales (K Units), Revenue and Growth Rate
Table Rimantadine-Sales (K Units), Revenue and Growth Rate
Table World Amantadine Revenue (M USD) and Growth Rate
Table Asia Pacific Influenza Drugs Sales by Type (2014-2020)
Figure Asia Pacific Influenza Drugs Sales Market Share by Type (2014-2020)
Table Asia Pacific Influenza Drugs Revenue by Type (2014-2020)
Figure Asia Pacific Influenza Drugs Revenue Market Share by Type (2014-2020)
Table Key Players in Asia Pacific
Table North America Influenza Drugs Sales by Type (2014-2020)
Figure North America Influenza Drugs Sales Market Share by Type (2014-2020)
Table North America Influenza Drugs Revenue by Type (2014-2020)
Figure North America Influenza Drugs Revenue Market Share by Type (2014-2020)
Table Key Players in North America
Table Europe Influenza Drugs Sales by Type (2014-2020)
Figure Europe Influenza Drugs Sales Market Share by Type (2014-2020)
Table Europe Influenza Drugs Revenue by Type (2014-2020)
Figure Europe Influenza Drugs Revenue Market Share by Type (2014-2020)
Table Key Players in Europe
Table South America Influenza Drugs Sales by Type (2014-2020)
Figure South America Influenza Drugs Sales Market Share by Type (2014-2020)
Table South America Influenza Drugs Revenue by Type (2014-2020)
Figure South America Influenza Drugs Revenue Market Share by Type (2014-2020)
Table Key Players in South America
Table Middle East and Africa Influenza Drugs Sales by Type (2014-2020)
Figure Middle East and Africa Influenza Drugs Sales Market Share by Type (2014-2020)
Table Middle East and Africa Influenza Drugs Revenue by Type (2014-2020)
Figure Middle East and Africa Influenza Drugs Revenue Market Share by Type (2014-2020)
Table Key Players in Middle East and Africa
Table World Influenza Drugs Consumption by Application (2014-2020)
Table World Influenza Drugs Consumption Market Share by Application (2014-2020)
Table Asia Influenza Drugs Consumption by Application (2014-2020)
Table Asia Influenza Drugs Consumption Market Share by Application (2014-2020)
Table North America Influenza Drugs Consumption by Application (2014-2020)
Table North America Influenza Drugs Consumption Market Share by Application (2014-2020)
Table Europe Influenza Drugs Consumption by Application (2014-2020)
Table Europe Influenza Drugs Consumption Market Share by Application (2014-2020)
Table South America Influenza Drugs Consumption by Application (2014-2020)
Table South America Influenza Drugs Consumption Market Share by Application (2014-2020)
Table Middle East and Africa Influenza Drugs Consumption by Application (2014-2020)
Table Middle East and Africa Influenza Drugs Consumption Market Share by Application (2014-2020)
Table Roche Profiles
Table Roche Product Information
Table Roche Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Roche Influenza Drugs Sales Market Share 2014-2020
Table Roche Influenza Drugs Market Status Change 2014-2020
Table Shionogi Profiles
Table Shionogi Product Information
Table Shionogi Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Shionogi Influenza Drugs Sales Market Share 2014-2020
Table Shionogi Influenza Drugs Market Status Change 2014-2020
Table Cipla Profiles
Table Cipla Product Information
Table Cipla Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Cipla Influenza Drugs Sales Market Share 2014-2020
Table Cipla Influenza Drugs Market Status Change 2014-2020
Table Sun Pharmaceutical Profiles
Table Sun Pharmaceutical Product Information
Table Sun Pharmaceutical Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Sun Pharmaceutical Influenza Drugs Sales Market Share 2014-2020
Table Sun Pharmaceutical Influenza Drugs Market Status Change 2014-2020
Table GlaxoSmithKline Profiles
Table GlaxoSmithKline Product Information
Table GlaxoSmithKline Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table GlaxoSmithKline Influenza Drugs Sales Market Share 2014-2020
Table GlaxoSmithKline Influenza Drugs Market Status Change 2014-2020
Table Mitsubishi Chemical Profiles
Table Mitsubishi Chemical Product Information
Table Mitsubishi Chemical Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Mitsubishi Chemical Influenza Drugs Sales Market Share 2014-2020
Table Mitsubishi Chemical Influenza Drugs Market Status Change 2014-2020
Table Daiichi Sankyo Profiles
Table Daiichi Sankyo Product Information
Table Daiichi Sankyo Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Daiichi Sankyo Influenza Drugs Sales Market Share 2014-2020
Table Daiichi Sankyo Influenza Drugs Market Status Change 2014-2020
Table ADMA Biologics Profiles
Table ADMA Biologics Product Information
Table ADMA Biologics Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table ADMA Biologics Influenza Drugs Sales Market Share 2014-2020
Table ADMA Biologics Influenza Drugs Market Status Change 2014-2020
Table Teva Profiles
Table Teva Product Information
Table Teva Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Teva Influenza Drugs Sales Middle East and Africa 2014-2020
Table Teva Influenza Drugs Market Status Change 2014-2020
Table CSL Profiles
Table CSL Product Information
Table CSL Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table CSL Influenza Drugs Sales Middle East and Africa 2014-2020
Table CSL Influenza Drugs Market Status Change 2014-2020
Table Sanofi Profiles
Table Sanofi Product Information
Table Sanofi Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Sanofi Influenza Drugs Sales Middle East and Africa 2014-2020
Table Sanofi Influenza Drugs Market Status Change 2014-2020
Table AstraZeneca Profiles
Table AstraZeneca Product Information
Table AstraZeneca Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table AstraZeneca Influenza Drugs Sales Middle East and Africa 2014-2020
Table AstraZeneca Influenza Drugs Market Status Change 2014-2020
Table Biondvax Profiles
Table Biondvax Product Information
Table Biondvax Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Biondvax Influenza Drugs Sales Middle East and Africa 2014-2020
Table Biondvax Influenza Drugs Market Status Change 2014-2020
Table HEC Profiles
Table HEC Product Information
Table HEC Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table HEC Influenza Drugs Sales Middle East and Africa 2014-2020
Table HEC Influenza Drugs Market Status Change 2014-2020
Table China Resources Sanjiu Profiles
Table China Resources Sanjiu Product Information
Table China Resources Sanjiu Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table China Resources Sanjiu Influenza Drugs Sales Middle East and Africa 2014-2020
Table China Resources Sanjiu Influenza Drugs Market Status Change 2014-2020
Table BaiYunShan General Factory (BYS) Profiles
Table BaiYunShan General Factory (BYS) Product Information
Table BaiYunShan General Factory (BYS) Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table BaiYunShan General Factory (BYS) Influenza Drugs Sales Middle East and Africa 2014-2020
Table BaiYunShan General Factory (BYS) Influenza Drugs Market Status Change 2014-2020
Table Livzon Pharm Profiles
Table Livzon Pharm Product Information
Table Livzon Pharm Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Livzon Pharm Influenza Drugs Sales Middle East and Africa 2014-2020
Table Livzon Pharm Influenza Drugs Market Status Change 2014-2020
Table Northeast Pharm Profiles
Table Northeast Pharm Product Information
Table Northeast Pharm Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Northeast Pharm Influenza Drugs Sales Middle East and Africa 2014-2020
Table Northeast Pharm Influenza Drugs Market Status Change 2014-2020
Table Others Profiles
Table Others Product Information
Table Others Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Others Influenza Drugs Sales Middle East and Africa 2014-2020
Table Others Influenza Drugs Market Status Change 2014-2020
Table Sales (Unit) of Players (2014-2020)
Table Sales Share of Players (2014-2020)
Figure World Influenza Drugs Sales Share in 2019
Table Revenue of Players (2014-2020)
Table Revenue Share of Players (2014-2020)
Figure World Influenza Drugs Revenue Share in 2019
Table Average Price of Players (2014-2020)
Figure Average Price of Players (2014-2020)
Table Gross Margin of Players (2014-2020)
Figure Gross Margin of Players in 2014
Figure Gross Margin of Players in 2019
Figure World Market Concentration (2014-2019)
Table Top 5 Players Sales Share (2014-2019)
Table Asia Pacific Influenza Drugs Sales (Unit) of Players (2014-2019)
Table Asia Pacific Influenza Drugs Sales Share of Players (2014-2019)
Figure Asia Pacific Influenza Drugs Sales Share in 2019
Table Asia Pacific Influenza Drugs Revenue of Players (2014-2019)
Table Asia Pacific Influenza Drugs Revenue Share of Players (2014-2019)
Figure Asia Pacific Influenza Drugs Revenue Share in 2019
Table Asia Pacific Influenza Drugs Price of Players (2014-2019)
Table Asia Pacific Influenza Drugs Gross Margin of Players (2014-2019)
Figure Asia Pacific Influenza Drugs Gross Margin Share in 2019
Figure Asia Pacific Market Concentration (2014-2019)
Table Top 5 Sales Share (2014-2019)
Table North America Influenza Drugs Sales (Unit) of Players (2014-2019)
Table North America Influenza Drugs Sales Share of Players (2014-2019)
Figure North America Influenza Drugs Sales Share in 2019
Table North America Influenza Drugs Revenue of Players (2014-2019)
Table North America Influenza Drugs Revenue Share of Players (2014-2019)
Figure North America Influenza Drugs Revenue Share in 2019
Table North America Influenza Drugs Price of Players (2014-2019)
Table North America Influenza Drugs Gross Margin of Players (2014-2019)
Figure North America Influenza Drugs Gross Margin Share in 2019
Figure North America Market Concentration (2014-2019)
Table Top 5 Sales Share (2014-2019)
Table Europe Influenza Drugs Sales (Unit) of Players (2014-2019)
Table Europe Influenza Drugs Sales Share of Players (2014-2019)
Figure Europe Influenza Drugs Sales Share in 2019
Table Europe Influenza Drugs Revenue of Players (2014-2019)
Table Europe Influenza Drugs Revenue Share of Players (2014-2019)
Figure Europe Influenza Drugs Revenue Share in 2019
Table Europe Influenza Drugs Price of Players (2014-2019)
Table Europe Influenza Drugs Gross Margin of Players (2014-2019)
Figure Europe Influenza Drugs Gross Margin Share in 2019
Figure Europe Market Concentration (2014-2019)
Table Top 5 Sales Share (2014-2019)
Table South America Influenza Drugs Sales (Unit) of Players (2014-2019)
Table South America Influenza Drugs Sales Share of Players (2014-2019)
Figure South America Influenza Drugs Sales Share in 2019
Table South America Influenza Drugs Revenue of Players (2014-2019)
Table South America Influenza Drugs Revenue Share of Players (2014-2019)
Figure South America Influenza Drugs Revenue Share in 2019
Table South America Influenza Drugs Price of Players (2014-2019)
Table South America Influenza Drugs Gross Margin of Players (2014-2019)
Figure South America Influenza Drugs Gross Margin Share in 2019
Figure South America Market Concentration (2014-2019)
Table Top 5 Sales Share (2014-2019)
Table Middle East and Africa Influenza Drugs Sales (Unit) of Players (2014-2019)
Table Middle East and Africa Influenza Drugs Sales Share of Players (2014-2019)
Figure Middle East and Africa Influenza Drugs Sales Share in 2019
Table Middle East and Africa Influenza Drugs Revenue of Players (2014-2019)
Table Middle East and Africa Influenza Drugs Revenue Share of Players (2014-2019)
Figure Middle East and Africa Influenza Drugs Revenue Share in 2019
Table Middle East and Africa Influenza Drugs Price of Players (2014-2019)
Table Middle East and Africa Influenza Drugs Gross Margin of Players (2014-2019)
Figure Middle East and Africa Influenza Drugs Gross Margin Share in 2019
Figure Middle East and Africa Market Concentration (2014-2019)
Table Top 5 Sales Share (2014-2019)
Table Asia Pacific Influenza Drugs Sales by Countries/Region (2014-2020)
Figure Asia Pacific Influenza Drugs Sales and Growth Rate (2014-2020)
Table Asia Pacific Influenza Drugs Sales Share by Countries/Region (2014-2020)
Figure Asia Pacific Influenza Drugs Sales Share by Countries/Region in 2019
Table Asia Pacific Influenza Drugs Revenue (Million USD) by Countries (2014-2020)
Figure Asia Pacific Influenza Drugs Revenue and Growth Rate (2014-2020)
Table Asia Pacific Influenza Drugs Revenue Share by Countries/Region (2014-2020)
Figure Asia Pacific Influenza Drugs Revenue Share by Countries/Region in 2019
Table Asia Pacific Influenza Drugs Average Price (USD/Unit) by Countries (2014-2020)
Table North America Influenza Drugs Sales by Countries/Region (2014-2020)
Figure North America Influenza Drugs Sales and Growth Rate (2014-2020)
Table North America Influenza Drugs Sales Share by Countries/Region (2014-2020)
Figure North America Influenza Drugs Sales Share by Countries/Region in 2019
Table North America Influenza Drugs Revenue (Million USD) by Countries (2014-2020)
Figure North America Influenza Drugs Revenue and Growth Rate (2014-2020)
Table North America Influenza Drugs Revenue Share by Countries/Region (2014-2020)
Figure North America Influenza Drugs Revenue Share by Countries/Region in 2019
Table North America Influenza Drugs Average Price (USD/Unit) by Countries (2014-2020)
Table Europe Influenza Drugs Sales by Countries/Region (2014-2020)
Figure Europe Influenza Drugs Sales and Growth Rate (2014-2020)
Table Europe Influenza Drugs Sales Share by Countries/Region (2014-2020)
Figure Europe Influenza Drugs Sales Share by Countries/Region in 2019
Table Europe Influenza Drugs Revenue (Million USD) by Countries (2014-2020)
Figure Europe Influenza Drugs Revenue and Growth Rate (2014-2020)
Table Europe Influenza Drugs Revenue Share by Countries/Region (2014-2020)
Figure Europe Influenza Drugs Revenue Share by Countries/Region in 2019
Table Europe Influenza Drugs Average Price (USD/Unit) by Countries (2014-2020)
Table South America Influenza Drugs Sales by Countries/Region (2014-2020)
Figure South America Influenza Drugs Sales and Growth Rate (2014-2020)
Table South America Influenza Drugs Sales Share by Countries/Region (2014-2020)
Figure South America Influenza Drugs Sales Share by Countries/Region in 2019
Table South America Influenza Drugs Revenue (Million USD) by Countries (2014-2020)
Figure South America Influenza Drugs Revenue and Growth Rate (2014-2020)
Table South America Influenza Drugs Revenue Share by Countries/Region (2014-2020)
Figure South America Influenza Drugs Revenue Share by Countries/Region in 2019
Table South America Influenza Drugs Average Price (USD/Unit) by Countries (2014-2020)
Table Middle East and Africa Influenza Drugs Sales by Countries/Region (2014-2020)
Figure Middle East and Africa Influenza Drugs Sales and Growth Rate (2014-2020)
Table Middle East and Africa Influenza Drugs Sales Share by Countries/Region (2014-2020)
Figure Middle East and Africa Influenza Drugs Sales Share by Countries/Region in 2019
Table Middle East and Africa Influenza Drugs Revenue (Million USD) by Countries (2014-2020)
Figure Middle East and Africa Influenza Drugs Revenue and Growth Rate (2014-2020)
Table Middle East and Africa Influenza Drugs Revenue Share by Countries/Region (2014-2020)
Figure Middle East and Africa Influenza Drugs Revenue Share by Countries/Region in 2019
Table Middle East and Africa Influenza Drugs Average Price (USD/Unit) by Countries (2014-2020)
Table Key Opportunities and Drivers
Table World Influenza Drugs Sales (Unit) by Regions (2020-2025)
Figure World Influenza Drugs Sales (Unit) and Growth Rate (2020-2025)
Table World Influenza Drugs Sales Share by Regions (2020-2025)
Figure World Influenza Drugs Sales Share by Regions in 2025
Table World Influenza Drugs Revenue by Regions (2020-2025)
Figure World Influenza Drugs Revenue and Growth Rate (2020-2025)
Table World Influenza Drugs Revenue Share by Regions (2020-2025)
Figure World Influenza Drugs Revenue Share by Regions in 2025
Table Sales (Unit) & Revenue (Million USD), 2020-2025
Figure Sales (Unit) and Growth Rate (2020-2025)
Figure Revenue (Million USD) and Growth Rate (2020-2025)
Table Sales (Unit) & Revenue (Million USD), 2020-2025
Figure Sales (Unit) and Growth Rate (2020-2025)
Figure Revenue (Million USD) and Growth Rate (2020-2025)
Table Sales (Unit) & Revenue (Million USD), 2020-2025
Table Consumption (K Units) Forecast by Application (2020-2025)
Figure Consumption (K Units) Forecast by Application (2020-2025)
Figure World Price (USD/Unit) Trend (2020-2025)
Figure World Gross Profit Trend (2020-2025)
Global Influenza Drugs Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Influenza Drugs Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Oseltamivir Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Zanamivir Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.3 Amantadine Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.4 Rimantadine Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Influenza Drugs Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Influenza Drugs Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Influenza Drugs Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Influenza Drugs Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Influenza Drugs Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Influenza Drugs Market Assessment by Type
8.1 Asia Pacific Influenza Drugs Market Assessment by Application (Consumption and Market Share)
8.2 North America Influenza Drugs Market Assessment by Application (Consumption and Market Share)
8.3 Europe Influenza Drugs Market Assessment by Application (Consumption and Market Share)
8.4 South America Influenza Drugs Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Influenza Drugs Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Roche
9.1.1 Roche Profiles
9.1.2 Roche Product Portfolio
9.1.3 Roche Influenza Drugs Business Performance
9.1.4 Roche Influenza Drugs Business Development and Market Status
9.2 Shionogi
9.2.1 Shionogi Profiles
9.2.2 Shionogi Product Portfolio
9.2.3 Shionogi Influenza Drugs Business Performance
9.2.4 Shionogi Influenza Drugs Business Development and Market Status
9.3 Cipla
9.3.1 Cipla Profiles
9.3.2 Cipla Product Portfolio
9.3.3 Cipla Influenza Drugs Business Performance
9.3.4 Cipla Influenza Drugs Business Development and Market Status
9.4 Sun Pharmaceutical
9.4.1 Sun Pharmaceutical Profiles
9.4.2 Sun Pharmaceutical Product Portfolio
9.4.3 Sun Pharmaceutical Influenza Drugs Business Performance
9.4.4 Sun Pharmaceutical Influenza Drugs Business Development and Market Status
9.5 GlaxoSmithKline
9.5.1 GlaxoSmithKline Profiles
9.5.2 GlaxoSmithKline Product Portfolio
9.5.3 GlaxoSmithKline Influenza Drugs Business Performance
9.5.4 GlaxoSmithKline Influenza Drugs Business Development and Market Status
9.6 Mitsubishi Chemical
9.6.1 Mitsubishi Chemical Profiles
9.6.2 Mitsubishi Chemical Product Portfolio
9.6.3 Mitsubishi Chemical Influenza Drugs Business Performance
9.6.4 Mitsubishi Chemical Influenza Drugs Business Development and Market Status
9.7 Daiichi Sankyo
9.7.1 Daiichi Sankyo Profiles
9.7.2 Daiichi Sankyo Product Portfolio
9.7.3 Daiichi Sankyo Influenza Drugs Business Performance
9.7.4 Daiichi Sankyo Influenza Drugs Business Development and Market Status
9.8 ADMA Biologics
9.8.1 ADMA Biologics Profiles
9.8.2 ADMA Biologics Product Portfolio
9.8.3 ADMA Biologics Influenza Drugs Business Performance
9.8.4 ADMA Biologics Influenza Drugs Business Development and Market Status
9.9 Teva
9.9.1 Teva Profiles
9.9.2 Teva Product Portfolio
9.9.3 Teva Influenza Drugs Business Performance
9.9.4 Teva Influenza Drugs Business Development and Market Status
9.10 CSL
9.10.1 CSL Profiles
9.10.2 CSL Product Portfolio
9.10.3 CSL Influenza Drugs Business Performance
9.10.4 CSL Influenza Drugs Business Development and Market Status
9.11 Sanofi
9.12 AstraZeneca
9.13 Biondvax
9.14 HEC
9.15 China Resources Sanjiu
9.16 BaiYunShan General Factory (BYS)
9.17 Livzon Pharm
9.18 Northeast Pharm
9.19 Others
10 World Influenza Drugs Market Assessment by Players
10.1 Global Influenza Drugs Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Influenza Drugs Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Influenza Drugs Price (USD/Unit) of Players 2014-2020
10.4 Global Influenza Drugs Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Influenza Drugs Sales Assessment of Players 2014-2020
11.1.2 North America Influenza Drugs Revenue Assessment of Players 2014-2020
11.1.3 North America Influenza Drugs Price Assessment of Players 2014-2020
11.1.4 North America Influenza Drugs Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Influenza Drugs Sales Assessment of Players 2014-2020
11.2.2 Europe Influenza Drugs Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Influenza Drugs Price Assessment of Players 2014-2020
11.2.4 Europe Influenza Drugs Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Influenza Drugs Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Influenza Drugs Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Influenza Drugs Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Influenza Drugs Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Influenza Drugs Sales Assessment of Players 2014-2020
11.4.2 South America Influenza Drugs Revenue Assessment of Players 2014-2020
11.4.3 South America Influenza Drugs Price Assessment of Players 2014-2020
11.4.4 South America Influenza Drugs Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Influenza Drugs Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Influenza Drugs Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Influenza Drugs Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Influenza Drugs Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Influenza Drugs Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Influenza Drugs Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Influenza Drugs Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Influenza Drugs Sales by Countries/Regions 2014-2020
12.2.2 North America Influenza Drugs Revenue by Countries/Regions 2014-2020
12.2.3 North America Influenza Drugs Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Influenza Drugs Sales by Countries/Regions 2014-2020
12.3.2 Europe Influenza Drugs Revenue by Countries/Regions 2014-2020
12.3.3 Europe Influenza Drugs Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Influenza Drugs Sales by Countries/Regions 2014-2020
12.4.2 South America Influenza Drugs Revenue by Countries/Regions 2014-2020
12.4.3 South America Influenza Drugs Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Influenza Drugs Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Influenza Drugs Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Influenza Drugs Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Influenza Drugs Sales & Revenue Forecast 2021-2026
14.1 World Influenza Drugs Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World Influenza DrugsSales and Market Share by Regions
14.1.2 World Influenza DrugsRevenue and Market Share by Regions
15 Asia Influenza Drugs Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 Oseltamivir
15.1.2 Zanamivir
15.1.3 Amantadine
15.1.4 Rimantadine
15.2 Consumption Forecast by Application, 2021-2026
16 North America Influenza Drugs Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 Oseltamivir
16.1.2 Zanamivir
16.1.3 Amantadine
16.1.4 Rimantadine
16.2 Consumption Forecast by Application, 2021-2026
17 Europe Influenza Drugs Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 Oseltamivir
17.1.2 Zanamivir
17.1.3 Amantadine
17.1.4 Rimantadine
17.2 Consumption Forecast by Application, 2021-2026
18 South America Influenza Drugs Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 Oseltamivir
18.1.2 Zanamivir
18.1.3 Amantadine
18.1.4 Rimantadine
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Influenza Drugs Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 Oseltamivir
19.1.2 Zanamivir
19.1.3 Amantadine
19.1.4 Rimantadine
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Influenza Drugs Price (USD/Unit) Trend 2021-2026
20.2 Global Influenza Drugs Gross Profit Trend 2021-2026
21 Conclusion
List of Tables and Figures
Figure Product Picture of Influenza Drugs
Table Players List in the Report
Table Mergers & Acquisitions, Expansion Plans
Table Global Influenza Drugs Market Size (Volume) and Growth Rate by Type (2019-2026)
Global Influenza Drugs Market Share by Application (2019-2026)
Figure Industry Chain Structure of Influenza Drugs
Table Product Application and Standard
Table Key Suppliers of Raw Material/Components
Figure Industry Chain Structure of Influenza Drugs
Table Representative Downstream Enterprises of Influenza Drugs
Figure New Project SWOT Analysis of Influenza Drugs
Table Industry Policy List of Influenza Drugs 2019
Table World Influenza Drugs Sales (Unit) by Type (2014-2020)
Figure World Influenza Drugs Sales Market Share (%) by Type 2014-2020
Table World 2014-2020 Influenza Drugs Revenue (M USD) by Type
Figure World Influenza Drugs Revenue Market Share (%) by Type 2014-2020
Table Oseltamivir-Sales (K Units), Revenue and Growth Rate
Table Zanamivir-Sales (K Units), Revenue and Growth Rate
Table Amantadine-Sales (K Units), Revenue and Growth Rate
Table Rimantadine-Sales (K Units), Revenue and Growth Rate
Table World Amantadine Revenue (M USD) and Growth Rate
Table Asia Pacific Influenza Drugs Sales by Type (2014-2020)
Figure Asia Pacific Influenza Drugs Sales Market Share by Type (2014-2020)
Table Asia Pacific Influenza Drugs Revenue by Type (2014-2020)
Figure Asia Pacific Influenza Drugs Revenue Market Share by Type (2014-2020)
Table Key Players in Asia Pacific
Table North America Influenza Drugs Sales by Type (2014-2020)
Figure North America Influenza Drugs Sales Market Share by Type (2014-2020)
Table North America Influenza Drugs Revenue by Type (2014-2020)
Figure North America Influenza Drugs Revenue Market Share by Type (2014-2020)
Table Key Players in North America
Table Europe Influenza Drugs Sales by Type (2014-2020)
Figure Europe Influenza Drugs Sales Market Share by Type (2014-2020)
Table Europe Influenza Drugs Revenue by Type (2014-2020)
Figure Europe Influenza Drugs Revenue Market Share by Type (2014-2020)
Table Key Players in Europe
Table South America Influenza Drugs Sales by Type (2014-2020)
Figure South America Influenza Drugs Sales Market Share by Type (2014-2020)
Table South America Influenza Drugs Revenue by Type (2014-2020)
Figure South America Influenza Drugs Revenue Market Share by Type (2014-2020)
Table Key Players in South America
Table Middle East and Africa Influenza Drugs Sales by Type (2014-2020)
Figure Middle East and Africa Influenza Drugs Sales Market Share by Type (2014-2020)
Table Middle East and Africa Influenza Drugs Revenue by Type (2014-2020)
Figure Middle East and Africa Influenza Drugs Revenue Market Share by Type (2014-2020)
Table Key Players in Middle East and Africa
Table World Influenza Drugs Consumption by Application (2014-2020)
Table World Influenza Drugs Consumption Market Share by Application (2014-2020)
Table Asia Influenza Drugs Consumption by Application (2014-2020)
Table Asia Influenza Drugs Consumption Market Share by Application (2014-2020)
Table North America Influenza Drugs Consumption by Application (2014-2020)
Table North America Influenza Drugs Consumption Market Share by Application (2014-2020)
Table Europe Influenza Drugs Consumption by Application (2014-2020)
Table Europe Influenza Drugs Consumption Market Share by Application (2014-2020)
Table South America Influenza Drugs Consumption by Application (2014-2020)
Table South America Influenza Drugs Consumption Market Share by Application (2014-2020)
Table Middle East and Africa Influenza Drugs Consumption by Application (2014-2020)
Table Middle East and Africa Influenza Drugs Consumption Market Share by Application (2014-2020)
Table Roche Profiles
Table Roche Product Information
Table Roche Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Roche Influenza Drugs Sales Market Share 2014-2020
Table Roche Influenza Drugs Market Status Change 2014-2020
Table Shionogi Profiles
Table Shionogi Product Information
Table Shionogi Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Shionogi Influenza Drugs Sales Market Share 2014-2020
Table Shionogi Influenza Drugs Market Status Change 2014-2020
Table Cipla Profiles
Table Cipla Product Information
Table Cipla Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Cipla Influenza Drugs Sales Market Share 2014-2020
Table Cipla Influenza Drugs Market Status Change 2014-2020
Table Sun Pharmaceutical Profiles
Table Sun Pharmaceutical Product Information
Table Sun Pharmaceutical Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Sun Pharmaceutical Influenza Drugs Sales Market Share 2014-2020
Table Sun Pharmaceutical Influenza Drugs Market Status Change 2014-2020
Table GlaxoSmithKline Profiles
Table GlaxoSmithKline Product Information
Table GlaxoSmithKline Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table GlaxoSmithKline Influenza Drugs Sales Market Share 2014-2020
Table GlaxoSmithKline Influenza Drugs Market Status Change 2014-2020
Table Mitsubishi Chemical Profiles
Table Mitsubishi Chemical Product Information
Table Mitsubishi Chemical Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Mitsubishi Chemical Influenza Drugs Sales Market Share 2014-2020
Table Mitsubishi Chemical Influenza Drugs Market Status Change 2014-2020
Table Daiichi Sankyo Profiles
Table Daiichi Sankyo Product Information
Table Daiichi Sankyo Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Daiichi Sankyo Influenza Drugs Sales Market Share 2014-2020
Table Daiichi Sankyo Influenza Drugs Market Status Change 2014-2020
Table ADMA Biologics Profiles
Table ADMA Biologics Product Information
Table ADMA Biologics Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table ADMA Biologics Influenza Drugs Sales Market Share 2014-2020
Table ADMA Biologics Influenza Drugs Market Status Change 2014-2020
Table Teva Profiles
Table Teva Product Information
Table Teva Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Teva Influenza Drugs Sales Middle East and Africa 2014-2020
Table Teva Influenza Drugs Market Status Change 2014-2020
Table CSL Profiles
Table CSL Product Information
Table CSL Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table CSL Influenza Drugs Sales Middle East and Africa 2014-2020
Table CSL Influenza Drugs Market Status Change 2014-2020
Table Sanofi Profiles
Table Sanofi Product Information
Table Sanofi Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Sanofi Influenza Drugs Sales Middle East and Africa 2014-2020
Table Sanofi Influenza Drugs Market Status Change 2014-2020
Table AstraZeneca Profiles
Table AstraZeneca Product Information
Table AstraZeneca Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table AstraZeneca Influenza Drugs Sales Middle East and Africa 2014-2020
Table AstraZeneca Influenza Drugs Market Status Change 2014-2020
Table Biondvax Profiles
Table Biondvax Product Information
Table Biondvax Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Biondvax Influenza Drugs Sales Middle East and Africa 2014-2020
Table Biondvax Influenza Drugs Market Status Change 2014-2020
Table HEC Profiles
Table HEC Product Information
Table HEC Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table HEC Influenza Drugs Sales Middle East and Africa 2014-2020
Table HEC Influenza Drugs Market Status Change 2014-2020
Table China Resources Sanjiu Profiles
Table China Resources Sanjiu Product Information
Table China Resources Sanjiu Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table China Resources Sanjiu Influenza Drugs Sales Middle East and Africa 2014-2020
Table China Resources Sanjiu Influenza Drugs Market Status Change 2014-2020
Table BaiYunShan General Factory (BYS) Profiles
Table BaiYunShan General Factory (BYS) Product Information
Table BaiYunShan General Factory (BYS) Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table BaiYunShan General Factory (BYS) Influenza Drugs Sales Middle East and Africa 2014-2020
Table BaiYunShan General Factory (BYS) Influenza Drugs Market Status Change 2014-2020
Table Livzon Pharm Profiles
Table Livzon Pharm Product Information
Table Livzon Pharm Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Livzon Pharm Influenza Drugs Sales Middle East and Africa 2014-2020
Table Livzon Pharm Influenza Drugs Market Status Change 2014-2020
Table Northeast Pharm Profiles
Table Northeast Pharm Product Information
Table Northeast Pharm Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Northeast Pharm Influenza Drugs Sales Middle East and Africa 2014-2020
Table Northeast Pharm Influenza Drugs Market Status Change 2014-2020
Table Others Profiles
Table Others Product Information
Table Others Influenza Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Others Influenza Drugs Sales Middle East and Africa 2014-2020
Table Others Influenza Drugs Market Status Change 2014-2020
Table Sales (Unit) of Players (2014-2020)
Table Sales Share of Players (2014-2020)
Figure World Influenza Drugs Sales Share in 2019
Table Revenue of Players (2014-2020)
Table Revenue Share of Players (2014-2020)
Figure World Influenza Drugs Revenue Share in 2019
Table Average Price of Players (2014-2020)
Figure Average Price of Players (2014-2020)
Table Gross Margin of Players (2014-2020)
Figure Gross Margin of Players in 2014
Figure Gross Margin of Players in 2019
Figure World Market Concentration (2014-2019)
Table Top 5 Players Sales Share (2014-2019)
Table Asia Pacific Influenza Drugs Sales (Unit) of Players (2014-2019)
Table Asia Pacific Influenza Drugs Sales Share of Players (2014-2019)
Figure Asia Pacific Influenza Drugs Sales Share in 2019
Table Asia Pacific Influenza Drugs Revenue of Players (2014-2019)
Table Asia Pacific Influenza Drugs Revenue Share of Players (2014-2019)
Figure Asia Pacific Influenza Drugs Revenue Share in 2019
Table Asia Pacific Influenza Drugs Price of Players (2014-2019)
Table Asia Pacific Influenza Drugs Gross Margin of Players (2014-2019)
Figure Asia Pacific Influenza Drugs Gross Margin Share in 2019
Figure Asia Pacific Market Concentration (2014-2019)
Table Top 5 Sales Share (2014-2019)
Table North America Influenza Drugs Sales (Unit) of Players (2014-2019)
Table North America Influenza Drugs Sales Share of Players (2014-2019)
Figure North America Influenza Drugs Sales Share in 2019
Table North America Influenza Drugs Revenue of Players (2014-2019)
Table North America Influenza Drugs Revenue Share of Players (2014-2019)
Figure North America Influenza Drugs Revenue Share in 2019
Table North America Influenza Drugs Price of Players (2014-2019)
Table North America Influenza Drugs Gross Margin of Players (2014-2019)
Figure North America Influenza Drugs Gross Margin Share in 2019
Figure North America Market Concentration (2014-2019)
Table Top 5 Sales Share (2014-2019)
Table Europe Influenza Drugs Sales (Unit) of Players (2014-2019)
Table Europe Influenza Drugs Sales Share of Players (2014-2019)
Figure Europe Influenza Drugs Sales Share in 2019
Table Europe Influenza Drugs Revenue of Players (2014-2019)
Table Europe Influenza Drugs Revenue Share of Players (2014-2019)
Figure Europe Influenza Drugs Revenue Share in 2019
Table Europe Influenza Drugs Price of Players (2014-2019)
Table Europe Influenza Drugs Gross Margin of Players (2014-2019)
Figure Europe Influenza Drugs Gross Margin Share in 2019
Figure Europe Market Concentration (2014-2019)
Table Top 5 Sales Share (2014-2019)
Table South America Influenza Drugs Sales (Unit) of Players (2014-2019)
Table South America Influenza Drugs Sales Share of Players (2014-2019)
Figure South America Influenza Drugs Sales Share in 2019
Table South America Influenza Drugs Revenue of Players (2014-2019)
Table South America Influenza Drugs Revenue Share of Players (2014-2019)
Figure South America Influenza Drugs Revenue Share in 2019
Table South America Influenza Drugs Price of Players (2014-2019)
Table South America Influenza Drugs Gross Margin of Players (2014-2019)
Figure South America Influenza Drugs Gross Margin Share in 2019
Figure South America Market Concentration (2014-2019)
Table Top 5 Sales Share (2014-2019)
Table Middle East and Africa Influenza Drugs Sales (Unit) of Players (2014-2019)
Table Middle East and Africa Influenza Drugs Sales Share of Players (2014-2019)
Figure Middle East and Africa Influenza Drugs Sales Share in 2019
Table Middle East and Africa Influenza Drugs Revenue of Players (2014-2019)
Table Middle East and Africa Influenza Drugs Revenue Share of Players (2014-2019)
Figure Middle East and Africa Influenza Drugs Revenue Share in 2019
Table Middle East and Africa Influenza Drugs Price of Players (2014-2019)
Table Middle East and Africa Influenza Drugs Gross Margin of Players (2014-2019)
Figure Middle East and Africa Influenza Drugs Gross Margin Share in 2019
Figure Middle East and Africa Market Concentration (2014-2019)
Table Top 5 Sales Share (2014-2019)
Table Asia Pacific Influenza Drugs Sales by Countries/Region (2014-2020)
Figure Asia Pacific Influenza Drugs Sales and Growth Rate (2014-2020)
Table Asia Pacific Influenza Drugs Sales Share by Countries/Region (2014-2020)
Figure Asia Pacific Influenza Drugs Sales Share by Countries/Region in 2019
Table Asia Pacific Influenza Drugs Revenue (Million USD) by Countries (2014-2020)
Figure Asia Pacific Influenza Drugs Revenue and Growth Rate (2014-2020)
Table Asia Pacific Influenza Drugs Revenue Share by Countries/Region (2014-2020)
Figure Asia Pacific Influenza Drugs Revenue Share by Countries/Region in 2019
Table Asia Pacific Influenza Drugs Average Price (USD/Unit) by Countries (2014-2020)
Table North America Influenza Drugs Sales by Countries/Region (2014-2020)
Figure North America Influenza Drugs Sales and Growth Rate (2014-2020)
Table North America Influenza Drugs Sales Share by Countries/Region (2014-2020)
Figure North America Influenza Drugs Sales Share by Countries/Region in 2019
Table North America Influenza Drugs Revenue (Million USD) by Countries (2014-2020)
Figure North America Influenza Drugs Revenue and Growth Rate (2014-2020)
Table North America Influenza Drugs Revenue Share by Countries/Region (2014-2020)
Figure North America Influenza Drugs Revenue Share by Countries/Region in 2019
Table North America Influenza Drugs Average Price (USD/Unit) by Countries (2014-2020)
Table Europe Influenza Drugs Sales by Countries/Region (2014-2020)
Figure Europe Influenza Drugs Sales and Growth Rate (2014-2020)
Table Europe Influenza Drugs Sales Share by Countries/Region (2014-2020)
Figure Europe Influenza Drugs Sales Share by Countries/Region in 2019
Table Europe Influenza Drugs Revenue (Million USD) by Countries (2014-2020)
Figure Europe Influenza Drugs Revenue and Growth Rate (2014-2020)
Table Europe Influenza Drugs Revenue Share by Countries/Region (2014-2020)
Figure Europe Influenza Drugs Revenue Share by Countries/Region in 2019
Table Europe Influenza Drugs Average Price (USD/Unit) by Countries (2014-2020)
Table South America Influenza Drugs Sales by Countries/Region (2014-2020)
Figure South America Influenza Drugs Sales and Growth Rate (2014-2020)
Table South America Influenza Drugs Sales Share by Countries/Region (2014-2020)
Figure South America Influenza Drugs Sales Share by Countries/Region in 2019
Table South America Influenza Drugs Revenue (Million USD) by Countries (2014-2020)
Figure South America Influenza Drugs Revenue and Growth Rate (2014-2020)
Table South America Influenza Drugs Revenue Share by Countries/Region (2014-2020)
Figure South America Influenza Drugs Revenue Share by Countries/Region in 2019
Table South America Influenza Drugs Average Price (USD/Unit) by Countries (2014-2020)
Table Middle East and Africa Influenza Drugs Sales by Countries/Region (2014-2020)
Figure Middle East and Africa Influenza Drugs Sales and Growth Rate (2014-2020)
Table Middle East and Africa Influenza Drugs Sales Share by Countries/Region (2014-2020)
Figure Middle East and Africa Influenza Drugs Sales Share by Countries/Region in 2019
Table Middle East and Africa Influenza Drugs Revenue (Million USD) by Countries (2014-2020)
Figure Middle East and Africa Influenza Drugs Revenue and Growth Rate (2014-2020)
Table Middle East and Africa Influenza Drugs Revenue Share by Countries/Region (2014-2020)
Figure Middle East and Africa Influenza Drugs Revenue Share by Countries/Region in 2019
Table Middle East and Africa Influenza Drugs Average Price (USD/Unit) by Countries (2014-2020)
Table Key Opportunities and Drivers
Table World Influenza Drugs Sales (Unit) by Regions (2020-2025)
Figure World Influenza Drugs Sales (Unit) and Growth Rate (2020-2025)
Table World Influenza Drugs Sales Share by Regions (2020-2025)
Figure World Influenza Drugs Sales Share by Regions in 2025
Table World Influenza Drugs Revenue by Regions (2020-2025)
Figure World Influenza Drugs Revenue and Growth Rate (2020-2025)
Table World Influenza Drugs Revenue Share by Regions (2020-2025)
Figure World Influenza Drugs Revenue Share by Regions in 2025
Table Sales (Unit) & Revenue (Million USD), 2020-2025
Figure Sales (Unit) and Growth Rate (2020-2025)
Figure Revenue (Million USD) and Growth Rate (2020-2025)
Table Sales (Unit) & Revenue (Million USD), 2020-2025
Figure Sales (Unit) and Growth Rate (2020-2025)
Figure Revenue (Million USD) and Growth Rate (2020-2025)
Table Sales (Unit) & Revenue (Million USD), 2020-2025
Table Consumption (K Units) Forecast by Application (2020-2025)
Figure Consumption (K Units) Forecast by Application (2020-2025)
Figure World Price (USD/Unit) Trend (2020-2025)
Figure World Gross Profit Trend (2020-2025)
RESEARCH METHODOLOGY
A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.
Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.
Now let’s take a closer look at the research methods here.
Secondary Research Model
Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.
Primary Insights
Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.
However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.
Market Estimation
The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.
Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.
Final Presentation
The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.
You can also purchase parts of this report. Do you want to check out a section wise price list?
Personalized Business Report Tailored to Your Requirements
- Our expert analysts collaborate directly with you to comprehend your specific needs.
- Get data on regions, segments, competitors, and vendors of your choice.
- Information is presented in alignment with your exact preferences and formatting.
Free Sample Report
"Find new revenue generation opportunities"